• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TORAX MEDICAL, INC. UNK LINX MAGNETIC IMPLANT; ANTI-REFLUX IMPLANT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TORAX MEDICAL, INC. UNK LINX MAGNETIC IMPLANT; ANTI-REFLUX IMPLANT Back to Search Results
Catalog Number UNK LINX MAGNETIC IMPLANT
Device Problems Device Appears to Trigger Rejection (1524); Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Dysphagia/ Odynophagia (1815); Pain (1994); Vomiting (2144)
Event Date 01/01/2020
Event Type  Injury  
Manufacturer Narrative
(b)(4).Only event year known: 2020; captured as citation date.As the device was not returned, an analysis investigation could not be performed.A conclusion could not be reached as to what may have caused or contributed to the event.The lot number was not provided; therefore, a manufacturing record evaluation could not be performed.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.
 
Event Description
It was reported via journal article: title: safety and efficacy of an implantable device for management of gastroesophageal reflux in lung transplant recipients author: samantha e.Halpern, aryaman gupta, vignesh raman, oliver k.Jawitz, ashley y.Choi, hai salfity, john c.Haney, jacob a.Klapper, matthew g.Hartwig citation: not reported doi: not reported this study is consisted of 14 lung transplant recipients (ltx) with gerd who underwent treatment with linx reflux management system (msa device) (ethicon) between 2017-2019.Persistent dysphagia requiring device dilation (n=3), subsequent device explant (n=2) at day 77 and 448 after implantation, vomiting (n=unknown) and throat pain (n=unknown) were the reported complications.Ltx recipients who underwent linx device implantation demonstrated a significant decrease in esophageal acid exposure time without major complications up to 12 months post-operatively.Use of the linx msa is a safe and effective method for management of post-ltx gerd in this highrisk population.
 
Manufacturer Narrative
(b)(4).Date sent: 3/17/2021.H10: this report is related to a journal article; therefore, no product will be returned for analysis and the manufacturing records cannot be reviewed as the lot/batch number has not been provided.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
UNK LINX MAGNETIC IMPLANT
Type of Device
ANTI-REFLUX IMPLANT
Manufacturer (Section D)
TORAX MEDICAL, INC.
4188 lexington avenue north
shoreview MN
MDR Report Key11504791
MDR Text Key241615467
Report Number3008766073-2021-00039
Device Sequence Number1
Product Code LEI
Combination Product (y/n)N
PMA/PMN Number
P100049
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type literature
Type of Report Initial,Followup
Report Date 03/08/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberUNK LINX MAGNETIC IMPLANT
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 03/17/2021
Initial Date FDA Received03/17/2021
Supplement Dates Manufacturer Received03/17/2021
Supplement Dates FDA Received03/17/2021
Is This a Reprocessed and Reused Single-Use Device? Yes
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-